Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07127874) titled 'A Study of PHN-012 in Patients With Advanced Solid Tumors' on Aug. 11.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Pheon Therapeutics
Condition:
Colon Cancer
Pancreatic Cancer
Lung Cancer (NSCLC)
Advanced Cancer
Advanced Solid Tumors
Intervention:
Drug: PHN-012
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
Target Sample Size: 165
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07...